shortagewatch

Home / Nervous system / Ketamine

ATC N01AX03 · Other General Anesthetics · updated 2 Nov 2026

Ketamine shortage

As of 2 Nov 2026, Ketamine has a reported shortage in 1 of the 16 countries we track (United States), covering 1 product from 1 company.

Is there a Ketamine shortage?

Yes. As of 2 Nov 2026, Ketamine is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

Countries1/16
Products1packs or presentations
Companies11 listed
Short since7 Nov 202512 months ago
Earliest returnnot givencompany estimate
Main reasonNot stated

Timeline

United States
2026Ketamine Hydrochloride, Injection, 500 mg/5mKetamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Pfizer1 PFE

Listed: Pfizer PFE · NYSE

Compared with similar medicines

ATC group N01AX · Other General Anesthetics
Propofol6/16Etomidate3/16Esketamine1/16Ketamine1/16Sodium Oxybate1/16

Affected products

CountryProductCompanySinceExpected backReason
USKetamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10) discontinuationPfizer Inc.7 Nov 2025not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Ketamine shortage?

Yes. As of 2 Nov 2026, Ketamine is reported short in 1 of the 16 countries we track: United States. No company has given a return date.

When will Ketamine be back in stock?

No return date has been given; United States: no date given. These are company estimates reported to each authority.

Why is Ketamine in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Ketamine shortages?

Pfizer.